GL1X · GenesisL1 explorer

MolNFT v1 · #152469 · protein

USP14 catalytic domain with IU1-206

6IIM · Ubiquitin carboxyl-terminal hydrolase 14: “USP14 catalytic domain with IU1-206”. X-ray diffraction, 1 ligand (A8L), 6 pockets (best druggability 0.54). MolNFT v1 #152469 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6IIM
Type
protein
Length
669 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ubiquitin carboxyl-terminal hydrolase 14
EC
3.4.19.12
UniProt
P54578
Ligands
A8L
Pockets
6 · best druggability 0.54

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUbiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12)protein33832% helix, 30% strandP54578
BUbiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12)protein33132% helix, 28% strandP54578

Ligands and binding sites

  • A8L · 1-[1-(4-chlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(4-hydroxypiperidin-1-yl)ethan-1-one · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1750.540.8616A8L
2730.480.8316A8L
31750.460.7629empty
41770.450.7422empty
51420.430.7626empty

Interfaces

1 interface between chains.

  • A–B · 779 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 6IIM · USP14 catalytic domain with IU1-206 · the same entry in another collection · chain A against A, TM-score 1.00
  • P54578 · AlphaFold monomer V2.0 prediction for ubiquitin carboxyl-terminal hydrolase 14 (P54578) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.